Evidence map›Paper›PMID 34591862›Full record

Observational studyPLoS medicine2021

Postmortem investigations and identification of multiple causes of child deaths: An analysis of findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) network.

Robert F Breiman, Dianna M Blau, Portia Mutevedzi, Victor Akelo, Inacio Mandomando, Ikechukwu U Ogbuanu, Samba O Sow, Lola Madrid, Shams El Arifeen, Mischka Garel and 30 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PLoS medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. [High diagnostic discrepancy in infectious diseases detected by autopsy].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Robert F BreimanDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-7099-2936
Dianna M BlauCenter for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Portia MutevedziSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Victor AkeloUS Centers for Disease Control and Prevention-Kenya, Kisumu, Kenya.ORCID 0000-0001-7518-2855
Inacio MandomandoCentro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.ORCID 0000-0002-1078-2187
Ikechukwu U OgbuanuCrown Agents, Freetown, Sierra Leone.ORCID 0000-0002-0670-6026
Samba O SowCentre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
Lola MadridDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Shams El ArifeenInternational Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.ORCID 0000-0002-5372-5932
Mischka GarelEmory Global Health Institute, Emory University, Atlanta, Georgia, United States of America.
Nana Bukiwe ThwalaSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0002-3948-3121
Dickens OnyangoKisumu County, Kenya Department of Health, Kisumu, Kenya.ORCID 0000-0002-1634-0531
Antonio SitoeCentro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.
Ima-Abasi BasseyICAP-Columbia University, Makeni, Sierra Leone.ORCID 0000-0001-8914-3638
Adama Mamby KeitaCentre pour le Développement des Vaccins (CVD-Mali), Ministère de la Santé, Bamako, Mali.
Addisu AlemuCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID 0000-0002-8219-6259
Muntasir AlamInternational Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.
Sana MahtabSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Dickson GethiKenya Medical Research Institute (KEMRI) Center for Global Health Research, Kisumu, Kenya.
Rosauro VaroCentro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.ORCID 0000-0003-4282-5572
Julius OjulongICAP-Columbia University, Makeni, Sierra Leone.ORCID 0000-0003-2200-8954
Solomon SamuraWorld Hope International, Makeni, Sierra Leone.
Ashka MehtaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Alexander M IbrahimCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID 0000-0003-4774-5416
Afruna RahmanInternational Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.ORCID 0000-0002-7693-2491
Pio VitorinoCentro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.
Vicky L BaillieSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0003-1327-9090
Janet AgayaKenya Medical Research Institute (KEMRI) Center for Global Health Research, Kisumu, Kenya.ORCID 0000-0003-1251-6621
Milagritos D TapiaCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Nega AssefaCollege of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID 0000-0003-0341-2329
Atique Iqbal ChowdhuryInternational Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.ORCID 0000-0001-9140-5983
J Anthony G ScottDepartment of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom.ORCID 0000-0001-7533-5006
Emily S GurleyInternational Center for Diarrhoeal Diseases Research (icddr,b), Dhaka, Bangladesh.ORCID 0000-0002-8648-9403
Karen L KotloffCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Amara JambaiMinistry of Health and Sanitation, Freetown, Sierra Leone.
Quique BassatCentro de Investigação em Saúde de Manhiça [CISM], Manhica, Mozambique.ORCID 0000-0003-0875-7596
Beth A Tippett-BarrUS Centers for Disease Control and Prevention-Kenya, Kisumu, Kenya.ORCID 0000-0001-5877-2968
Shabir A MadhiSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.ORCID 0000-0002-7629-0636
Cynthia G WhitneyDepartment of Global Health, Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
CHAMPS Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe current burden of >5 million deaths yearly is the focus of the Sustainable Development Goal (SDG) to end preventable deaths of newborns and children under 5 years old by 2030. To accelerate progression toward this goal, data are needed that accurately quantify the leading causes of death, so that interventions can target the common causes. By adding postmortem pathology and microbiology studies to other available data, the Child Health and Mortality Prevention Surveillance (CHAMPS) network provides comprehensive evaluations of conditions leading to death, in contrast to standard methods that rely on data from medical records and verbal autopsy and report only a single underlying condition. We analyzed CHAMPS data to characterize the value of considering multiple causes of death. METHODS AND

findingsWe examined deaths identified from December 2016 through November 2020 from 7 CHAMPS sites (in Bangladesh, Ethiopia, Kenya, Mali, Mozambique, Sierra Leone, and South Africa), including 741 neonatal, 278 infant, and 241 child <5 years deaths for which results from Determination of Cause of Death (DeCoDe) panels were complete. DeCoDe panelists included all conditions in the causal chain according to the ICD-10 guidelines and assessed if prevention or effective management of the condition would have prevented the death. We analyzed the distribution of all conditions listed as causal, including underlying, antecedent, and immediate causes of death. Among 1,232 deaths with an underlying condition determined, we found a range of 0 to 6 (mean 1.5, IQR 0 to 2) additional conditions in the causal chain leading to death. While pathology provides very helpful clues, we cannot always be certain that conditions identified led to death or occurred in an agonal stage of death. For neonates, preterm birth complications (most commonly respiratory distress syndrome) were the most common underlying condition (n = 282, 38%); among those with preterm birth complications, 256 (91%) had additional conditions in causal chains, including 184 (65%) with a different preterm birth complication, 128 (45%) with neonatal sepsis, 69 (24%) with lower respiratory infection (LRI), 60 (21%) with meningitis, and 25 (9%) with perinatal asphyxia/hypoxia. Of the 278 infant deaths, 212 (79%) had ≥1 additional cause of death (CoD) beyond the underlying cause. The 2 most common underlying conditions in infants were malnutrition and congenital birth defects; LRI and sepsis were the most common additional conditions in causal chains, each accounting for approximately half of deaths with either underlying condition. Of the 241 child deaths, 178 (75%) had ≥1 additional condition. Among 46 child deaths with malnutrition as the underlying condition, all had ≥1 other condition in the causal chain, most commonly sepsis, followed by LRI, malaria, and diarrheal disease. Including all positions in the causal chain for neonatal deaths resulted in 19-fold and 11-fold increases in attributable roles for meningitis and LRI, respectively. For infant deaths, the proportion caused by meningitis and sepsis increased by 16-fold and 11-fold, respectively; for child deaths, sepsis and LRI are increased 12-fold and 10-fold, respectively. While comprehensive CoD determinations were done for a substantial number of deaths, there is potential for bias regarding which deaths in surveillance areas underwent minimally invasive tissue sampling (MITS), potentially reducing representativeness of findings.

conclusionsIncluding conditions that appear anywhere in the causal chain, rather than considering underlying condition alone, markedly changed the proportion of deaths attributed to various diagnoses, especially LRI, sepsis, and meningitis. While CHAMPS methods cannot determine when 2 conditions cause death independently or may be synergistic, our findings suggest that considering the chain of events leading to death can better guide research and prevention priorities aimed at reducing child deaths.

Indexed as

AfricaAge FactorsAsiaAutopsyCause of DeathChild HealthChild MortalityChild, PreschoolFemaleGlobal Burden of DiseaseHumansInfantInfant HealthInfant MortalityInfant, NewbornMale

Identifiers

PMID34591862
PMCPMC8516282

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.